These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2038732)

  • 1. Bronchodilator treatment for partially reversible chronic obstructive airways disease.
    Tandon MK; Kailis SG
    Thorax; 1991 Apr; 46(4):248-51. PubMed ID: 2038732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease.
    Tandon MK
    Chest; 1993 Jan; 103(1):105-10. PubMed ID: 8380266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.
    Kerstjens HA; Brand PL; de Jong PM; Koëter GH; Postma DS
    Thorax; 1994 Nov; 49(11):1109-15. PubMed ID: 7831626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral terbutaline in chronic airflow limitation.
    Maltbaek N; Garsdal P; Christensen H; Bro H; Rasmussen FV
    Chest; 1989 Jun; 95(6):1248-52. PubMed ID: 2721259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiorespiratory effects of oral terbutaline and an ephedrine-theophylline-phenobarbital combination: comparison in patients with chronic obstructive ventilatory disorders.
    Cohen BM
    Ann Allergy; 1978 Apr; 40(4):233-9. PubMed ID: 345887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction.
    McDonald CF; Pierce RJ; Thompson PJ; Allen D; Bowler S; Breslin AB; Bowes G; Saunders N; Murree-Allen K; Frith P; Musk AW
    J Asthma; 1997; 34(1):53-9. PubMed ID: 9033440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma.
    Rühle KH; Dorow P; Schmitz-Schumann H
    Lung; 1990; 168 Suppl():192-3. PubMed ID: 1974676
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
    Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
    N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease.
    Chapman KR; Boucher S; Hyland RH; Day A; Kreisman H; Rivington R; Hodder RV; York EL; Abboud RT; Peters S
    J Allergy Clin Immunol; 1990 Feb; 85(2):514-21. PubMed ID: 2406328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
    Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
    Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhaled N-acetylcysteine in combination with terbutaline.
    Stiksa G; Nemcek K; Melin S
    Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.